Preparation of cytoplasmic membranes of Staphylococcus aureus FDA 209P through protoplasts made with the L-11 enzyme and a preliminary analysis of membrane antigens.
D000596:Amino Acids / Q000032:analysis; D000606:Amino Sugars / Q000032:analysis; D000818:Animals; D000941:Antigens / Q000032:analysis*; D002462:Cell Membrane / Q000276:immunology*; D002473:Cell Wall / Q000276:immunology; D005417:Flavobacterium / Q000201:enzymology; D006863:Hydrogen-Ion Concentration; D007106:Immune Sera; D005779:Immunodiffusion; D008854:Microscopy, Electron; D010447:Peptide Hydrolases / Q000494:pharmacology*; D011523:Protoplasts / Q000276:immunology*; D011817:Rabbits; D013053:Spectrophotometry; D013210:Staphylococcus / Q000276:immunology*; D013395:Sucrose; D014466:Ultraviolet Rays
D000596:Amino Acids; D000606:Amino Sugars; D000941:Antigens; D007106:Immune Sera; D013395:Sucrose; D010447:Peptide Hydrolases